Adropin Drives Glycolysis and EMT in Pancreatic Cancer via β₂-AR/β-Arrestin 2/ERK Signaling
A new study shows that the metabolic peptide Adropin promotes glycolytic reprogramming and EMT in pancreatic cancer through β₂-adrenergic receptor, ...
A new study shows that the metabolic peptide Adropin promotes glycolytic reprogramming and EMT in pancreatic cancer through β₂-adrenergic receptor, ...
Researchers report that the long noncoding RNA KCNMB2-AS1, activated by the transcription factor FOXP3, promotes clear cell renal cell carcinoma ...
A newly designed cell-penetrating peptide that inhibits the autophagy enzyme ATG4 raised reactive oxygen species and significantly reduced tumor size ...
A new study shows the transcription factors SIX1 and TEAD1 synergistically promote colorectal tumor growth by directly co-regulating the CTGF ...
A new Cell Division study reports that the transcription factor PRRX2 activates the CNTN3 gene, promoting epithelial-to-mesenchymal transition, proliferation and ...
A preclinical study reports that the EGFR inhibitor osimertinib and the XPO1 inhibitor selinexor synergistically deplete c-MYC and trigger nucleolar ...
A new study reports that the signaling protein VAV2 promotes glycolytic reprogramming and tumor growth in esophageal squamous cell carcinoma ...
A four-gene transcriptomic signature stratifies prostate cancer patients by biochemical recurrence risk and identifies SPAG5 as a targetable oncogene.
A new Biology Direct study shows that periplocin suppresses osteosarcoma cell proliferation and tumor growth in preclinical models by inducing ...
Nanoscale vesicle-like particles isolated from the medicinal herb Selaginella doederleinii suppressed liver cancer cells and tumors in mice by inducing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine